Literature DB >> 14572322

Assessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary care.

M Molimard1, C Raherison, S Lignot, F Depont, A Abouelfath, N Moore.   

Abstract

The correct use of inhalation devices is an inclusion criterion for all studies comparing inhaled treatments. In real life, however, patients may make many errors with their usual inhalation device, which may negate the benefits observed in clinical trials. Our study was undertaken to compare inhalation device handling in real life. A total of 3811 patients treated for at least 1 month with an inhalation device (Aerolizer, Autohaler, Diskus, pressurized metered dose inhaler (pMDI), or Turbuhaler) were included in this observational study performed in primary care in France between February 1st and July 14th, 2002. General practitioners had to assess patient handling of their usual inhaler device with the help of a checklist established for each inhaler model, from the package leaflet. Seventy-six percent of patients made at least one error with pMDI compared to 49-55% with breath-actuated inhalers. Errors compromising treatment efficacy were made by 11-12% of patients treated with Aerolizer, Autohaler, or Diskus compared to 28% and 32% of patients treated with pMDI and Turbuhaler, respectively. Overestimation of good inhalation by general practitioners was maximal for Turbuhaler (24%), and lowest for Autohaler and pMDI (6%). Ninety percent of general practitioners felt that participation in the study would improve error detection. These results suggest that there are differences in the handling of inhaler devices in real life in primary care that are not taken into account in controlled studies. There is a need for continued education of prescribers and users in the proper use of these devices to improve treatment efficacy.

Entities:  

Mesh:

Year:  2003        PMID: 14572322     DOI: 10.1089/089426803769017613

Source DB:  PubMed          Journal:  J Aerosol Med        ISSN: 0894-2684


  81 in total

1.  A randomized controlled trial of a literacy-sensitive self-management intervention for chronic obstructive pulmonary disease patients.

Authors:  Katie Kiser; Daniel Jonas; Zachary Warner; Kelli Scanlon; Betsy Bryant Shilliday; Darren A DeWalt
Journal:  J Gen Intern Med       Date:  2011-09-21       Impact factor: 5.128

2.  Comparison of small-group training with self-directed internet-based training in inhaler techniques.

Authors:  Mariam Toumas; Iman A Basheti; Sinthia Z Bosnic-Anticevich
Journal:  Am J Pharm Educ       Date:  2009-08-28       Impact factor: 2.047

3.  Inhaler devices for chronic obstructive pulmonary disease: insights from patients and healthcare practitioners.

Authors:  Mathieu Molimard; Paul Colthorpe
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2014-09-29       Impact factor: 2.849

4.  [Prise en charge pharmacologique de la BPCO: Un éventail de produits pour insuffler une bouffée d'air].

Authors:  Alex Crawley; Tessa Laubscher; Patricia Muddiman; Lynette Kosar
Journal:  Can Fam Physician       Date:  2016-05-12       Impact factor: 3.275

5.  Pharmacologic management of COPD: Breadth of products for encouraging a breath of air.

Authors:  Alex Crawley; Tessa Laubscher; Patricia Muddiman; Lynette Kosar
Journal:  Can Fam Physician       Date:  2016-05       Impact factor: 3.275

Review 6.  Routine Use of Budesonide/Formoterol Fixed Dose Combination in Elderly Asthmatic Patients: Practical Considerations.

Authors:  Nicola Scichilone; Fulvio Braido; Federico Lavorini; Mark L Levy; Omar S Usmani
Journal:  Drugs Aging       Date:  2017-05       Impact factor: 3.923

7.  Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.

Authors:  Dheeraj Gupta; Ritesh Agarwal; Ashutosh Nath Aggarwal; V N Maturu; Sahajal Dhooria; K T Prasad; Inderpaul S Sehgal; Lakshmikant B Yenge; Aditya Jindal; Navneet Singh; A G Ghoshal; G C Khilnani; J K Samaria; S N Gaur; D Behera
Journal:  Lung India       Date:  2013-07

8.  Comparing usability of NEXThaler(®) with other inhaled corticosteroid/long-acting β2-agonist fixed combination dry powder inhalers in asthma patients.

Authors:  Thomas Voshaar; Monica Spinola; Patrick Linnane; Alice Campanini; Daniel Lock; Anthony Lafratta; Mario Scuri; Barbara Ronca; Andrea S Melani
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2013-12-03       Impact factor: 2.849

Review 9.  In vitro considerations to support bioequivalence of locally acting drugs in dry powder inhalers for lung diseases.

Authors:  Sau Lawrence Lee; Wallace P Adams; Bing V Li; Dale P Conner; Badrul A Chowdhury; Lawrence X Yu
Journal:  AAPS J       Date:  2009-06-03       Impact factor: 4.009

Review 10.  Turning a molecule into a medicine: the development of indacaterol as a novel once-daily bronchodilator treatment for patients with COPD.

Authors:  Lorraine Murphy; Stephen Rennard; James Donohue; Mathieu Molimard; Ronald Dahl; Kai-Michael Beeh; Juergen Dederichs; Hans-Jürgen Fülle; Mark Higgins; David Young
Journal:  Drugs       Date:  2014-09       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.